Downregulation of connective tissue growth factor by LPS/IFN-γ-induced nitric oxide is reversed by aristolochic acid treatment in glomerular mesangial cells via STAT-1α and NF-κB signaling
•LPS/IFN-γ-induced NO downregulates CTGF protein expression in MES-13 cells.•AA significantly suppressed LPS/IFN-γ-induced NO production in MES-13 cells.•AA significantly reversed CTGF expression that was downregulated by LPS/IFN-γ.•AA decreased STAT-1α phosphorylation and IRF-1 mRNA expression in M...
Saved in:
Published in | Chemico-biological interactions Vol. 210; pp. 86 - 95 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Ireland
Elsevier Ireland Ltd
05.03.2014
|
Subjects | |
Online Access | Get full text |
ISSN | 0009-2797 1872-7786 1872-7786 |
DOI | 10.1016/j.cbi.2013.12.017 |
Cover
Abstract | •LPS/IFN-γ-induced NO downregulates CTGF protein expression in MES-13 cells.•AA significantly suppressed LPS/IFN-γ-induced NO production in MES-13 cells.•AA significantly reversed CTGF expression that was downregulated by LPS/IFN-γ.•AA decreased STAT-1α phosphorylation and IRF-1 mRNA expression in MES-13 cells.•AA attenuated IKB phosphorylation and reduced NF-κB activation in MES-13 cells.
Aristolochic acid (AA) is a common cause of Chinese herb nephropathy. The mechanisms involved in the pathogenesis of AA nephropathy (AAN) are intricate. One well-documented effect of AA in the kidney is its pro-fibrotic activity. Nitric oxide (NO), a messenger gas generated from l-arginine, is the product of nitric oxide synthase (NOS). NO is involved in renal hemodynamics and exerts cytoprotective effects against renal injury. In the present study, the role of NO in AAN was investigated in MES-13 cells, a glomerular mesangial cell line. NO endogenously generated by the induction of inducible nitric oxide synthase (iNOS) with lipopolysaccharide (LPS)/interferon-γ (IFN-γ) significantly downregulated connective tissue growth factor (CTGF) protein expression in MES-13 cells. AA significantly suppressed LPS/IFN-γ-induced NO production and reversed CTGF expression that was downregulated by LPS/IFN-γ. AA decreased iNOS gene and protein expressions in a concentration-dependent manner. AA caused declines in LPS/IFN-γ-induced signal transducer and activator of transcription-1α (STAT-1α) phosphorylation and interferon response factor-1 (IRF-1) mRNA expression. Furthermore, AA attenuated IκB phosphorylation and reduced NF-κB translocation to the nuclear fraction. Taken together, our data indicate that AA reversed the CTGF expression inhibited by LPS/IFN-γ treatment via suppression of NO and iNOS expressions in MES-13 cells through inhibition of the JAK/STAT-1α and NF-κB signaling pathways. NO potentially exerts antifibrotic activity by down regulation of CTGF in MES-13 cells and inhibition of the iNOS gene by AA might partially account for the fibrotic effects of AA in nephropathy. |
---|---|
AbstractList | Aristolochic acid (AA) is a common cause of Chinese herb nephropathy. The mechanisms involved in the pathogenesis of AA nephropathy (AAN) are intricate. One well-documented effect of AA in the kidney is its pro-fibrotic activity. Nitric oxide (NO), a messenger gas generated from l-arginine, is the product of nitric oxide synthase (NOS). NO is involved in renal hemodynamics and exerts cytoprotective effects against renal injury. In the present study, the role of NO in AAN was investigated in MES-13 cells, a glomerular mesangial cell line. NO endogenously generated by the induction of inducible nitric oxide synthase (iNOS) with lipopolysaccharide (LPS)/interferon-γ (IFN-γ) significantly downregulated connective tissue growth factor (CTGF) protein expression in MES-13 cells. AA significantly suppressed LPS/IFN-γ-induced NO production and reversed CTGF expression that was downregulated by LPS/IFN-γ. AA decreased iNOS gene and protein expressions in a concentration-dependent manner. AA caused declines in LPS/IFN-γ-induced signal transducer and activator of transcription-1α (STAT-1α) phosphorylation and interferon response factor-1 (IRF-1) mRNA expression. Furthermore, AA attenuated IκB phosphorylation and reduced NF-κB translocation to the nuclear fraction. Taken together, our data indicate that AA reversed the CTGF expression inhibited by LPS/IFN-γ treatment via suppression of NO and iNOS expressions in MES-13 cells through inhibition of the JAK/STAT-1α and NF-κB signaling pathways. NO potentially exerts antifibrotic activity by down regulation of CTGF in MES-13 cells and inhibition of the iNOS gene by AA might partially account for the fibrotic effects of AA in nephropathy.Aristolochic acid (AA) is a common cause of Chinese herb nephropathy. The mechanisms involved in the pathogenesis of AA nephropathy (AAN) are intricate. One well-documented effect of AA in the kidney is its pro-fibrotic activity. Nitric oxide (NO), a messenger gas generated from l-arginine, is the product of nitric oxide synthase (NOS). NO is involved in renal hemodynamics and exerts cytoprotective effects against renal injury. In the present study, the role of NO in AAN was investigated in MES-13 cells, a glomerular mesangial cell line. NO endogenously generated by the induction of inducible nitric oxide synthase (iNOS) with lipopolysaccharide (LPS)/interferon-γ (IFN-γ) significantly downregulated connective tissue growth factor (CTGF) protein expression in MES-13 cells. AA significantly suppressed LPS/IFN-γ-induced NO production and reversed CTGF expression that was downregulated by LPS/IFN-γ. AA decreased iNOS gene and protein expressions in a concentration-dependent manner. AA caused declines in LPS/IFN-γ-induced signal transducer and activator of transcription-1α (STAT-1α) phosphorylation and interferon response factor-1 (IRF-1) mRNA expression. Furthermore, AA attenuated IκB phosphorylation and reduced NF-κB translocation to the nuclear fraction. Taken together, our data indicate that AA reversed the CTGF expression inhibited by LPS/IFN-γ treatment via suppression of NO and iNOS expressions in MES-13 cells through inhibition of the JAK/STAT-1α and NF-κB signaling pathways. NO potentially exerts antifibrotic activity by down regulation of CTGF in MES-13 cells and inhibition of the iNOS gene by AA might partially account for the fibrotic effects of AA in nephropathy. •LPS/IFN-γ-induced NO downregulates CTGF protein expression in MES-13 cells.•AA significantly suppressed LPS/IFN-γ-induced NO production in MES-13 cells.•AA significantly reversed CTGF expression that was downregulated by LPS/IFN-γ.•AA decreased STAT-1α phosphorylation and IRF-1 mRNA expression in MES-13 cells.•AA attenuated IKB phosphorylation and reduced NF-κB activation in MES-13 cells. Aristolochic acid (AA) is a common cause of Chinese herb nephropathy. The mechanisms involved in the pathogenesis of AA nephropathy (AAN) are intricate. One well-documented effect of AA in the kidney is its pro-fibrotic activity. Nitric oxide (NO), a messenger gas generated from l-arginine, is the product of nitric oxide synthase (NOS). NO is involved in renal hemodynamics and exerts cytoprotective effects against renal injury. In the present study, the role of NO in AAN was investigated in MES-13 cells, a glomerular mesangial cell line. NO endogenously generated by the induction of inducible nitric oxide synthase (iNOS) with lipopolysaccharide (LPS)/interferon-γ (IFN-γ) significantly downregulated connective tissue growth factor (CTGF) protein expression in MES-13 cells. AA significantly suppressed LPS/IFN-γ-induced NO production and reversed CTGF expression that was downregulated by LPS/IFN-γ. AA decreased iNOS gene and protein expressions in a concentration-dependent manner. AA caused declines in LPS/IFN-γ-induced signal transducer and activator of transcription-1α (STAT-1α) phosphorylation and interferon response factor-1 (IRF-1) mRNA expression. Furthermore, AA attenuated IκB phosphorylation and reduced NF-κB translocation to the nuclear fraction. Taken together, our data indicate that AA reversed the CTGF expression inhibited by LPS/IFN-γ treatment via suppression of NO and iNOS expressions in MES-13 cells through inhibition of the JAK/STAT-1α and NF-κB signaling pathways. NO potentially exerts antifibrotic activity by down regulation of CTGF in MES-13 cells and inhibition of the iNOS gene by AA might partially account for the fibrotic effects of AA in nephropathy. Aristolochic acid (AA) is a common cause of Chinese herb nephropathy. The mechanisms involved in the pathogenesis of AA nephropathy (AAN) are intricate. One well-documented effect of AA in the kidney is its pro-fibrotic activity. Nitric oxide (NO), a messenger gas generated from l-arginine, is the product of nitric oxide synthase (NOS). NO is involved in renal hemodynamics and exerts cytoprotective effects against renal injury. In the present study, the role of NO in AAN was investigated in MES-13 cells, a glomerular mesangial cell line. NO endogenously generated by the induction of inducible nitric oxide synthase (iNOS) with lipopolysaccharide (LPS)/interferon-γ (IFN-γ) significantly downregulated connective tissue growth factor (CTGF) protein expression in MES-13 cells. AA significantly suppressed LPS/IFN-γ-induced NO production and reversed CTGF expression that was downregulated by LPS/IFN-γ. AA decreased iNOS gene and protein expressions in a concentration-dependent manner. AA caused declines in LPS/IFN-γ-induced signal transducer and activator of transcription-1α (STAT-1α) phosphorylation and interferon response factor-1 (IRF-1) mRNA expression. Furthermore, AA attenuated IκB phosphorylation and reduced NF-κB translocation to the nuclear fraction. Taken together, our data indicate that AA reversed the CTGF expression inhibited by LPS/IFN-γ treatment via suppression of NO and iNOS expressions in MES-13 cells through inhibition of the JAK/STAT-1α and NF-κB signaling pathways. NO potentially exerts antifibrotic activity by down regulation of CTGF in MES-13 cells and inhibition of the iNOS gene by AA might partially account for the fibrotic effects of AA in nephropathy. |
Author | Tsai, Kuen-daw Chen, Wei Tseng, Min-Jen Wu, Hsing-Yu Wang, Sue-Hong Chi, Jhih-Ying Wong, Ho-Yiu Lin, Ting-Hui Hsiao, Yu-Wei Lee, Yi-Ju |
Author_xml | – sequence: 1 givenname: Kuen-daw surname: Tsai fullname: Tsai, Kuen-daw organization: Department of Internal Medicine, China Medical University and Beigang Hospital, 123, Sinde Road, Beigang Township, Yunlin County 65152, Taiwan, ROC – sequence: 2 givenname: Wei surname: Chen fullname: Chen, Wei organization: Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Chia-Yi Christian Hospital, Chiayi, Taiwan, ROC – sequence: 3 givenname: Sue-Hong surname: Wang fullname: Wang, Sue-Hong organization: Department of Biomedical Sciences, Chung Shan Medical University, No. 110, Jianguo North Road, Section 1, Taichung 40203, Taiwan, ROC – sequence: 4 givenname: Yu-Wei surname: Hsiao fullname: Hsiao, Yu-Wei organization: Department of Biomedical Sciences, Chung Shan Medical University, No. 110, Jianguo North Road, Section 1, Taichung 40203, Taiwan, ROC – sequence: 5 givenname: Jhih-Ying surname: Chi fullname: Chi, Jhih-Ying organization: Department of Biomedical Sciences, Chung Shan Medical University, No. 110, Jianguo North Road, Section 1, Taichung 40203, Taiwan, ROC – sequence: 6 givenname: Hsing-Yu surname: Wu fullname: Wu, Hsing-Yu organization: Department of Biomedical Sciences, Chung Shan Medical University, No. 110, Jianguo North Road, Section 1, Taichung 40203, Taiwan, ROC – sequence: 7 givenname: Yi-Ju surname: Lee fullname: Lee, Yi-Ju organization: Institute of Microbiology and Immunology, Chung Shan Medical University, No. 110, Jianguo North Road, Section 1, Taichung 40203, Taiwan, ROC – sequence: 8 givenname: Ho-Yiu surname: Wong fullname: Wong, Ho-Yiu organization: Department of Internal Medicine, China Medical University and Beigang Hospital, 123, Sinde Road, Beigang Township, Yunlin County 65152, Taiwan, ROC – sequence: 9 givenname: Min-Jen surname: Tseng fullname: Tseng, Min-Jen organization: Institute of Molecular Biology, National Chung Cheng University, 168 University Road, Minhsiung Township, Chiayi County 62102, Taiwan, ROC – sequence: 10 givenname: Ting-Hui surname: Lin fullname: Lin, Ting-Hui email: thlin@csmu.edu.tw, yylin2332@gmail.com organization: Department of Biomedical Sciences, Chung Shan Medical University, No. 110, Jianguo North Road, Section 1, Taichung 40203, Taiwan, ROC |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/24412304$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kUFu1DAUQCNURKeFA7BBXrLJ1HaccSJWpTBQaVSQOqwtx_lJ_yixi-1M6bEQOzbcYM6EhyksWHRlWX7P-vrvJDuyzkKWvWR0zihbnG3mpsE5p6yYMz6nTD7JZqySPJeyWhxlM0ppnXNZy-PsJIRNulIu6LPsmAvBeEHFLPv1zt1ZD_006IjOEtcR46wFE3ELJGIIE5Deu7t4QzptovOkuSerz9dnl8urfPcjR9tOBlpiMXo0xH3DFggG4mELPqSHhGuPIbrBmZtEaIMtiR50HMFGgpb0gxvBpwk8GSFo26MeiIFhCGSLmlyvz9c5230n2rbkapnvfr4lAXurB7T98-xpp4cALx7O0-zL8v364mO--vTh8uJ8lRu-qGIOxrCu6RrOBK-FqKqClV1ZaSMbWHDQpRAd6yRlbaG1rkpqqCmhFrysqk42tDjNXh_-vfXu6wQhqhHDfkZtwU1BMVHXTLBSlgl99YBOzQituvU4an-v_i49AewAGO9C8ND9QxhV-7Bqo1JYtQ-rGFcpbHLkf47B-CdZ9BqHR803BxPSerYIXgWDYFMz9Cmzah0-Yv8GxxTBwg |
CitedBy_id | crossref_primary_10_15407_ubj93_06_005 crossref_primary_10_3389_fphar_2020_569551 crossref_primary_10_3389_fcell_2021_809952 crossref_primary_10_1016_j_cbi_2016_06_029 crossref_primary_10_1007_s12079_020_00602_2 crossref_primary_10_1016_j_redox_2016_09_014 crossref_primary_10_1016_j_theriogenology_2018_03_038 crossref_primary_10_3389_fimmu_2017_00610 crossref_primary_10_3892_etm_2017_4297 crossref_primary_10_1155_2021_8877056 crossref_primary_10_1113_EP085333 |
Cites_doi | 10.1111/j.1524-475X.2007.00308.x 10.1111/j.1365-2362.2008.01941.x 10.1084/jem.177.6.1779 10.1080/10799890903078465 10.1093/nar/22.15.3033 10.1016/j.lfs.2003.10.042 10.1146/annurev.bi.64.070195.003201 10.1016/0162-3109(93)90061-T 10.1016/j.toxicon.2007.03.011 10.1016/0140-6736(93)92984-2 10.1111/j.1523-1755.1998.00820.x 10.1093/ndt/gfm667 10.1111/j.1523-1755.2004.00905.x 10.1093/ndt/16.suppl_1.60 10.1046/j.1523-1755.2002.00462.x 10.1002/path.2769 10.1006/niox.2001.0410 10.1016/j.matbio.2011.07.004 10.1093/carcin/bgm082 10.1152/ajprenal.00424.2007 10.1038/aps.2009.197 10.1016/0005-2760(89)90299-3 10.1016/j.ejphar.2004.07.030 10.1016/j.cbi.2011.03.012 10.1038/labinvest.3780182 10.1006/niox.2001.0421 10.1002/biof.30 10.1681/ASN.V7102202 10.1016/j.taap.2012.03.011 10.1097/00002281-200211000-00009 10.1515/BC.2007.056 10.1038/ni1001-907 10.1016/S0272-6386(97)90275-4 10.1146/annurev.immunol.021908.132641 10.1006/abio.1995.1079 10.1007/s004670200004 10.1681/ASN.2008060653 10.1016/j.niox.2007.10.005 10.1016/S0272-6386(00)70343-X |
ContentType | Journal Article |
Copyright | 2014 Elsevier Ireland Ltd Copyright © 2014 Elsevier Ireland Ltd. All rights reserved. |
Copyright_xml | – notice: 2014 Elsevier Ireland Ltd – notice: Copyright © 2014 Elsevier Ireland Ltd. All rights reserved. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1016/j.cbi.2013.12.017 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Anatomy & Physiology Chemistry Biology |
EISSN | 1872-7786 |
EndPage | 95 |
ExternalDocumentID | 24412304 10_1016_j_cbi_2013_12_017 S0009279714000088 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- --K --M -~X .~1 0R~ 1B1 1RT 1~. 1~5 29B 4.4 457 4G. 5GY 5RE 5VS 6J9 7-5 71M 8P~ 9JM AACTN AAEDT AAEDW AAIAV AAIKJ AAKOC AAOAW AAQFI AATCM AAXUO ABFRF ABFYP ABJNI ABLST ABMAC ABXDB ABYKQ ABZDS ACDAQ ACGFO ACGFS ACIUM ACRLP ADBBV ADEZE AEBSH AEFWE AEKER AENEX AFKWA AFTJW AFXIZ AGHFR AGUBO AGYEJ AHEUO AIEXJ AIKHN AITUG AJBFU AJOXV AKIFW ALCLG ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ AXJTR BKOJK BLECG BLXMC CS3 DU5 EBS EFJIC EFLBG EO8 EO9 EP2 EP3 F5P FDB FIRID FNPLU FYGXN G-Q GBLVA IHE J1W KCYFY KOM M34 M41 MO0 N9A O-L O9- OAUVE OGGZJ OZT P-8 P-9 P2P PC. Q38 RIG ROL RPZ SCC SDF SDG SDP SES SPCBC SSJ SSP SSZ T5K WH7 ~G- .GJ 3O- 53G AALRI AAQXK AATTM AAXKI AAYJJ AAYWO AAYXX ABEFU ABFNM ABWVN ACRPL ACVFH ADCNI ADMUD ADNMO ADVLN AEIPS AEUPX AFFNX AFJKZ AFPUW AGCQF AGQPQ AHHHB AI. AIGII AIIUN AKBMS AKRWK AKYEP ANKPU APXCP ASPBG AVWKF AZFZN CITATION EFKBS EJD FEDTE FGOYB G-2 HMT HVGLF HZ~ H~9 R2- SEW SPT VH1 WUQ ZGI ZXP ~HD CGR CUY CVF ECM EIF NPM SSH 7X8 |
ID | FETCH-LOGICAL-c268t-ecc1fbfb214294488315f58ac7be62ea544f1f701d3aaa850c0c5e942588f7b03 |
IEDL.DBID | AIKHN |
ISSN | 0009-2797 1872-7786 |
IngestDate | Fri Sep 05 06:31:33 EDT 2025 Thu Apr 03 06:59:49 EDT 2025 Thu Apr 24 22:54:56 EDT 2025 Thu Sep 18 00:11:58 EDT 2025 Fri Feb 23 02:31:33 EST 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | NO Glomerular mesangial cells TGF β CHN IRF-1 Aristolochic acid MTT LPS STAT-1α CTGF IκB NF-κB IFN-γ γ-IRE EMSA iNOS TNF α CKD AA TBS PDEs IKK PLA2 TBST Connective tissue growth factor CM Q-RT-PCR IL-1β MAPK AAN ECM JAK Nitric oxide GAS MES-13 cells PVDF membrane GAPDH TLR4 |
Language | English |
License | Copyright © 2014 Elsevier Ireland Ltd. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c268t-ecc1fbfb214294488315f58ac7be62ea544f1f701d3aaa850c0c5e942588f7b03 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 24412304 |
PQID | 1499141575 |
PQPubID | 23479 |
PageCount | 10 |
ParticipantIDs | proquest_miscellaneous_1499141575 pubmed_primary_24412304 crossref_primary_10_1016_j_cbi_2013_12_017 crossref_citationtrail_10_1016_j_cbi_2013_12_017 elsevier_sciencedirect_doi_10_1016_j_cbi_2013_12_017 |
PublicationCentury | 2000 |
PublicationDate | 2014-03-05 |
PublicationDateYYYYMMDD | 2014-03-05 |
PublicationDate_xml | – month: 03 year: 2014 text: 2014-03-05 day: 05 |
PublicationDecade | 2010 |
PublicationPlace | Ireland |
PublicationPlace_xml | – name: Ireland |
PublicationTitle | Chemico-biological interactions |
PublicationTitleAlternate | Chem Biol Interact |
PublicationYear | 2014 |
Publisher | Elsevier Ireland Ltd |
Publisher_xml | – name: Elsevier Ireland Ltd |
References | de Jonge, Vanrenterghem (b0025) 2008; 23 Kikuchi, Katsuramaki, Kukita, Taketani, Meguro, Nagayama, Isobe, Mizuguchi, Hirata (b0120) 2007; 15 Morrissey, Ishidoya, McCracken, Klahr (b0130) 1996; 7 Ito, Aten, Bende, Oemar, Rabelink, Weening, Goldschmeding (b0055) 1998; 53 Baylis (b0065) 2008; 294 Debelle, Nortier, Husson, De Prez, Vienne, Rombaut, Salmon, Deschodt-Lanckman, Vanherweghem (b0105) 2004; 66 Chen, Chiang, Wu, Kao, Hsiang, Ho, Lin (b0170) 2010; 31 Wu, Chou, Cheng, Hsiao, Wang, Wang, Sheu, Hsiao (b0175) 2011; 192 Hochberg, Johnson, Chen, Cohen, Stern, Vaughan, Poppas, Felsen (b0135) 2000; 80 Schindler, Darnell (b0080) 1995; 64 Rein, Muller, Zorbas (b0090) 1994; 22 Trachtman, Futterweit, Pine, Mann, Valderrama (b0140) 2002; 17 Moreno (b0190) 1993; 26 Vallabhapurapu, Karin (b0165) 2009; 27 Fragiadaki, Witherden, Kaneko, Sonnylal, Pusey, Bou-Gharios, Mason (b0060) 2011; 30 Verdon, Burton, Prior (b0075) 1995; 224 Ihn (b0050) 2002; 14 Ferrini, Vernet, Magee, Shahed, Qian, Rajfer, Gonzalez-Cadavid (b0125) 2002; 6 Kleinert, Pautz, Linker, Schwarz (b0095) 2004; 500 Lukivskaya, Patsenker, Lis, Buko (b0110) 2008; 38 Yang, Lin, Chang, Hsu (b0040) 2000; 35 Forstermann, Sessa (b0015) 2012; 33 Vivancos, Moreno (b0180) 2002; 6 Aktan (b0010) 2004; 75 Sims, Cha, Romine, Gao, Gottlieb, Deisseroth (b0160) 1993; 13 Kone (b0020) 1997; 30 Li, Zhang, Wang, Wang, Li, Wu (b0100) 2009; 29 Dreieicher, Beck, Lazaroski, Boosen, Tsalastra-Greul, Beck, Fleming, Schaefer, Pfeilschifter (b0145) 2009; 20 Cicha, Goppelt-Struebe (b0045) 2009; 35 Xie, Whisnant, Nathan (b0085) 1993; 177 Chen, Fan, Tseng, Ho, Hsu (b0205) 2007; 50 Lin, Hsieh, Lee, Liu, Lin (b0195) 2008; 18 Vanherweghem, Depierreux, Tielemans, Abramowicz, Dratwa, Jadoul, Richard, Vandervelde, Verbeelen, Vanhaelen-Fastre (b0035) 1993; 341 Rosenthal, Vishwanath, Franson (b0185) 1989; 1001 Klahr (b0070) 2001; 16 Wani, Carl, Henger, Nelson, Rupprecht (b0155) 2007; 388 Mihout, Shweke, Bige, Jouanneau, Dussaule, Ronco, Chatziantoniou, Boffa (b0115) 2011; 223 Keil, Blom, Goldschmeding, Rupprecht (b0150) 2002; 62 Ding, Chen (b0200) 2012; 261 Bogdan (b0005) 2001; 2 Arlt, Stiborova, vom Brocke, Simoes, Lord, Nortier, Hollstein, Phillips, Schmeiser (b0030) 2007; 28 Kone (10.1016/j.cbi.2013.12.017_b0020) 1997; 30 Schindler (10.1016/j.cbi.2013.12.017_b0080) 1995; 64 Kleinert (10.1016/j.cbi.2013.12.017_b0095) 2004; 500 Forstermann (10.1016/j.cbi.2013.12.017_b0015) 2012; 33 Kikuchi (10.1016/j.cbi.2013.12.017_b0120) 2007; 15 Aktan (10.1016/j.cbi.2013.12.017_b0010) 2004; 75 Vivancos (10.1016/j.cbi.2013.12.017_b0180) 2002; 6 de Jonge (10.1016/j.cbi.2013.12.017_b0025) 2008; 23 Klahr (10.1016/j.cbi.2013.12.017_b0070) 2001; 16 Vallabhapurapu (10.1016/j.cbi.2013.12.017_b0165) 2009; 27 Ferrini (10.1016/j.cbi.2013.12.017_b0125) 2002; 6 Rosenthal (10.1016/j.cbi.2013.12.017_b0185) 1989; 1001 Arlt (10.1016/j.cbi.2013.12.017_b0030) 2007; 28 Moreno (10.1016/j.cbi.2013.12.017_b0190) 1993; 26 Fragiadaki (10.1016/j.cbi.2013.12.017_b0060) 2011; 30 Keil (10.1016/j.cbi.2013.12.017_b0150) 2002; 62 Ihn (10.1016/j.cbi.2013.12.017_b0050) 2002; 14 Bogdan (10.1016/j.cbi.2013.12.017_b0005) 2001; 2 Wani (10.1016/j.cbi.2013.12.017_b0155) 2007; 388 Xie (10.1016/j.cbi.2013.12.017_b0085) 1993; 177 Lukivskaya (10.1016/j.cbi.2013.12.017_b0110) 2008; 38 Yang (10.1016/j.cbi.2013.12.017_b0040) 2000; 35 Cicha (10.1016/j.cbi.2013.12.017_b0045) 2009; 35 Dreieicher (10.1016/j.cbi.2013.12.017_b0145) 2009; 20 Morrissey (10.1016/j.cbi.2013.12.017_b0130) 1996; 7 Trachtman (10.1016/j.cbi.2013.12.017_b0140) 2002; 17 Wu (10.1016/j.cbi.2013.12.017_b0175) 2011; 192 Debelle (10.1016/j.cbi.2013.12.017_b0105) 2004; 66 Ito (10.1016/j.cbi.2013.12.017_b0055) 1998; 53 Chen (10.1016/j.cbi.2013.12.017_b0205) 2007; 50 Ding (10.1016/j.cbi.2013.12.017_b0200) 2012; 261 Li (10.1016/j.cbi.2013.12.017_b0100) 2009; 29 Chen (10.1016/j.cbi.2013.12.017_b0170) 2010; 31 Lin (10.1016/j.cbi.2013.12.017_b0195) 2008; 18 Rein (10.1016/j.cbi.2013.12.017_b0090) 1994; 22 Verdon (10.1016/j.cbi.2013.12.017_b0075) 1995; 224 Hochberg (10.1016/j.cbi.2013.12.017_b0135) 2000; 80 Baylis (10.1016/j.cbi.2013.12.017_b0065) 2008; 294 Mihout (10.1016/j.cbi.2013.12.017_b0115) 2011; 223 Vanherweghem (10.1016/j.cbi.2013.12.017_b0035) 1993; 341 Sims (10.1016/j.cbi.2013.12.017_b0160) 1993; 13 |
References_xml | – volume: 18 start-page: 93 year: 2008 end-page: 104 ident: b0195 article-title: AH23848 accelerates inducible nitric oxide synthase degradation through attenuation of cAMP signaling in glomerular mesangial cells publication-title: Nitric Oxide – volume: 30 start-page: 311 year: 1997 end-page: 333 ident: b0020 article-title: Nitric oxide in renal health and disease publication-title: Am. J. Kidney Dis. – volume: 294 start-page: F1 year: 2008 end-page: 9 ident: b0065 article-title: Nitric oxide deficiency in chronic kidney disease publication-title: Am. J. Physiol. Renal Physiol. – volume: 15 start-page: 881 year: 2007 end-page: 888 ident: b0120 article-title: New strategy for the antifibrotic therapy with oral administration of FR260330 (a selective inducible nitric oxide synthase inhibitor) in rat experimental liver cirrhosis publication-title: Wound Repair Regen. – volume: 6 start-page: 283 year: 2002 end-page: 294 ident: b0125 article-title: Antifibrotic role of inducible nitric oxide synthase publication-title: Nitric Oxide – volume: 28 start-page: 2253 year: 2007 end-page: 2261 ident: b0030 article-title: Aristolochic acid mutagenesis: molecular clues to the aetiology of Balkan endemic nephropathy-associated urothelial cancer publication-title: Carcinogenesis – volume: 261 start-page: 59 year: 2012 end-page: 65 ident: b0200 article-title: Developmental nephrotoxicity of aristolochic acid in a zebrafish model publication-title: Toxicol. Appl. Pharmacol. – volume: 26 start-page: 1 year: 1993 end-page: 9 ident: b0190 article-title: Effect of aristolochic acid on arachidonic acid cascade and in vivo models of inflammation publication-title: Immunopharmacology – volume: 33 year: 2012 ident: b0015 article-title: Nitric oxide synthases: regulation and function publication-title: Eur. Heart J. – volume: 29 start-page: 280 year: 2009 end-page: 285 ident: b0100 article-title: TGF-beta 1/Smads signaling stimulates renal interstitial fibrosis in experimental AAN publication-title: J. Recept. Signal Transduct. Res. – volume: 6 start-page: 255 year: 2002 end-page: 262 ident: b0180 article-title: Role of Ca(2+)-independent phospholipase A(2) and cyclooxygenase/lipoxygenase pathways in the nitric oxide production by murine macrophages stimulated by lipopolysaccharides publication-title: Nitric oxide – volume: 192 start-page: 209 year: 2011 end-page: 219 ident: b0175 article-title: Aristolochic acid downregulates monocytic matrix metalloproteinase-9 by inhibiting nuclear factor-kappaB activation publication-title: Chem. Biol. Interact. – volume: 27 start-page: 693 year: 2009 end-page: 733 ident: b0165 article-title: Regulation and function of NF-kappaB transcription factors in the immune system publication-title: Annu. Rev. Immunol. – volume: 38 start-page: 317 year: 2008 end-page: 325 ident: b0110 article-title: Inhibition of inducible nitric oxide synthase activity prevents liver recovery in rat thioacetamide-induced fibrosis reversal publication-title: Eur. J. Clin. Invest. – volume: 22 start-page: 3033 year: 1994 end-page: 3037 ident: b0090 article-title: In vivo footprinting of the IRF-1 promoter: inducible occupation of a GAS element next to a persistent structural alteration of the DNA publication-title: Nucleic Acids Res. – volume: 2 start-page: 907 year: 2001 end-page: 916 ident: b0005 article-title: Nitric oxide and the immune response publication-title: Nat. Immunol. – volume: 35 start-page: 313 year: 2000 end-page: 318 ident: b0040 article-title: Rapidly progressive fibrosing interstitial nephritis associated with Chinese herbal drugs publication-title: Am. J. Kidney Dis. – volume: 13 start-page: 690 year: 1993 end-page: 702 ident: b0160 article-title: A novel interferon-inducible domain: structural and functional analysis of the human interferon regulatory factor 1 gene promoter publication-title: Mol. Cell. Biol. – volume: 66 start-page: 1815 year: 2004 end-page: 1825 ident: b0105 article-title: The renin-angiotensin system blockade does not prevent renal interstitial fibrosis induced by aristolochic acids publication-title: Kidney Int. – volume: 17 start-page: 20 year: 2002 end-page: 29 ident: b0140 article-title: Chronic diabetic nephropathy: role of inducible nitric oxide synthase publication-title: Pediatr. Nephrol. – volume: 64 start-page: 621 year: 1995 end-page: 651 ident: b0080 article-title: Transcriptional responses to polypeptide ligands: the JAK-STAT pathway publication-title: Annu. Rev. Biochem. – volume: 224 start-page: 502 year: 1995 end-page: 508 ident: b0075 article-title: Sample pretreatment with nitrate reductase and glucose-6-phosphate dehydrogenase quantitatively reduces nitrate while avoiding interference by NADP+ when the Griess reaction is used to assay for nitrite publication-title: Anal. Biochem. – volume: 62 start-page: 401 year: 2002 end-page: 411 ident: b0150 article-title: Nitric oxide down-regulates connective tissue growth factor in rat mesangial cells publication-title: Kidney Int. – volume: 1001 start-page: 1 year: 1989 end-page: 8 ident: b0185 article-title: Effects of aristolochic acid on phospholipase A2 activity and arachidonate metabolism of human neutrophils publication-title: Biochim. Biophys. Acta – volume: 16 start-page: 60 year: 2001 end-page: 62 ident: b0070 article-title: The role of nitric oxide in hypertension and renal disease progression publication-title: Nephrol. Dial. Transplant. – volume: 23 start-page: 39 year: 2008 end-page: 41 ident: b0025 article-title: Aristolochic acid: the common culprit of Chinese herbs nephropathy and Balkan endemic nephropathy publication-title: Nephrol. Dial. Transplant. – volume: 30 start-page: 396 year: 2011 end-page: 403 ident: b0060 article-title: Interstitial fibrosis is associated with increased COL1A2 transcription in AA-injured renal tubular epithelial cells publication-title: Matrix Biol. – volume: 50 start-page: 180 year: 2007 end-page: 188 ident: b0205 article-title: Pharmacokinetics and nephrotoxicity of aristolochic acid in rabbits publication-title: Toxicon – volume: 14 start-page: 681 year: 2002 end-page: 685 ident: b0050 article-title: Pathogenesis of fibrosis: role of TGF-beta and CTGF publication-title: Curr. Opin. Rheumatol. – volume: 75 start-page: 639 year: 2004 end-page: 653 ident: b0010 article-title: INOS-mediated nitric oxide production and its regulation publication-title: Life Sci. – volume: 35 start-page: 200 year: 2009 end-page: 208 ident: b0045 article-title: Connective tissue growth factor: context-dependent functions and mechanisms of regulation publication-title: Biofactors – volume: 388 start-page: 497 year: 2007 end-page: 506 ident: b0155 article-title: Nitric oxide modulates expression of extracellular matrix genes linked to fibrosis in kidney mesangial cells publication-title: Biol. Chem. – volume: 31 start-page: 227 year: 2010 end-page: 236 ident: b0170 article-title: Microarray analysis reveals the inhibition of nuclear factor-kappa B signaling by aristolochic acid in normal human kidney (HK-2) cells publication-title: Acta Pharmacol. Sin. – volume: 341 start-page: 387 year: 1993 end-page: 391 ident: b0035 article-title: Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs publication-title: Lancet – volume: 7 start-page: 2202 year: 1996 end-page: 2212 ident: b0130 article-title: Nitric oxide generation ameliorates the tubulointerstitial fibrosis of obstructive nephropathy publication-title: J. Am. Soc. Nephrol. – volume: 177 start-page: 1779 year: 1993 end-page: 1784 ident: b0085 article-title: Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon gamma and bacterial lipopolysaccharide publication-title: J. Exp. Med. – volume: 20 start-page: 1963 year: 2009 end-page: 1974 ident: b0145 article-title: Nitric oxide inhibits glomerular TGF-beta signaling via SMOC-1 publication-title: J. Am. Soc. Nephrol. – volume: 53 start-page: 853 year: 1998 end-page: 861 ident: b0055 article-title: Expression of connective tissue growth factor in human renal fibrosis publication-title: Kidney Int. – volume: 80 start-page: 1721 year: 2000 end-page: 1728 ident: b0135 article-title: Interstitial fibrosis of unilateral ureteral obstruction is exacerbated in kidneys of mice lacking the gene for inducible nitric oxide synthase publication-title: Lab. Invest. – volume: 500 start-page: 255 year: 2004 end-page: 266 ident: b0095 article-title: Regulation of the expression of inducible nitric oxide synthase publication-title: Eur. J. Pharmacol. – volume: 223 start-page: 37 year: 2011 end-page: 45 ident: b0115 article-title: Asymmetric dimethylarginine (ADMA) induces chronic kidney disease through a mechanism involving collagen and TGF-beta1 synthesis publication-title: J. Pathol. – volume: 15 start-page: 881 year: 2007 ident: 10.1016/j.cbi.2013.12.017_b0120 article-title: New strategy for the antifibrotic therapy with oral administration of FR260330 (a selective inducible nitric oxide synthase inhibitor) in rat experimental liver cirrhosis publication-title: Wound Repair Regen. doi: 10.1111/j.1524-475X.2007.00308.x – volume: 38 start-page: 317 year: 2008 ident: 10.1016/j.cbi.2013.12.017_b0110 article-title: Inhibition of inducible nitric oxide synthase activity prevents liver recovery in rat thioacetamide-induced fibrosis reversal publication-title: Eur. J. Clin. Invest. doi: 10.1111/j.1365-2362.2008.01941.x – volume: 177 start-page: 1779 year: 1993 ident: 10.1016/j.cbi.2013.12.017_b0085 article-title: Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon gamma and bacterial lipopolysaccharide publication-title: J. Exp. Med. doi: 10.1084/jem.177.6.1779 – volume: 29 start-page: 280 year: 2009 ident: 10.1016/j.cbi.2013.12.017_b0100 article-title: TGF-beta 1/Smads signaling stimulates renal interstitial fibrosis in experimental AAN publication-title: J. Recept. Signal Transduct. Res. doi: 10.1080/10799890903078465 – volume: 13 start-page: 690 year: 1993 ident: 10.1016/j.cbi.2013.12.017_b0160 article-title: A novel interferon-inducible domain: structural and functional analysis of the human interferon regulatory factor 1 gene promoter publication-title: Mol. Cell. Biol. – volume: 22 start-page: 3033 year: 1994 ident: 10.1016/j.cbi.2013.12.017_b0090 article-title: In vivo footprinting of the IRF-1 promoter: inducible occupation of a GAS element next to a persistent structural alteration of the DNA publication-title: Nucleic Acids Res. doi: 10.1093/nar/22.15.3033 – volume: 75 start-page: 639 year: 2004 ident: 10.1016/j.cbi.2013.12.017_b0010 article-title: INOS-mediated nitric oxide production and its regulation publication-title: Life Sci. doi: 10.1016/j.lfs.2003.10.042 – volume: 64 start-page: 621 year: 1995 ident: 10.1016/j.cbi.2013.12.017_b0080 article-title: Transcriptional responses to polypeptide ligands: the JAK-STAT pathway publication-title: Annu. Rev. Biochem. doi: 10.1146/annurev.bi.64.070195.003201 – volume: 26 start-page: 1 year: 1993 ident: 10.1016/j.cbi.2013.12.017_b0190 article-title: Effect of aristolochic acid on arachidonic acid cascade and in vivo models of inflammation publication-title: Immunopharmacology doi: 10.1016/0162-3109(93)90061-T – volume: 50 start-page: 180 year: 2007 ident: 10.1016/j.cbi.2013.12.017_b0205 article-title: Pharmacokinetics and nephrotoxicity of aristolochic acid in rabbits publication-title: Toxicon doi: 10.1016/j.toxicon.2007.03.011 – volume: 341 start-page: 387 year: 1993 ident: 10.1016/j.cbi.2013.12.017_b0035 article-title: Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs publication-title: Lancet doi: 10.1016/0140-6736(93)92984-2 – volume: 53 start-page: 853 year: 1998 ident: 10.1016/j.cbi.2013.12.017_b0055 article-title: Expression of connective tissue growth factor in human renal fibrosis publication-title: Kidney Int. doi: 10.1111/j.1523-1755.1998.00820.x – volume: 23 start-page: 39 year: 2008 ident: 10.1016/j.cbi.2013.12.017_b0025 article-title: Aristolochic acid: the common culprit of Chinese herbs nephropathy and Balkan endemic nephropathy publication-title: Nephrol. Dial. Transplant. doi: 10.1093/ndt/gfm667 – volume: 66 start-page: 1815 year: 2004 ident: 10.1016/j.cbi.2013.12.017_b0105 article-title: The renin-angiotensin system blockade does not prevent renal interstitial fibrosis induced by aristolochic acids publication-title: Kidney Int. doi: 10.1111/j.1523-1755.2004.00905.x – volume: 16 start-page: 60 issue: Suppl. 1 year: 2001 ident: 10.1016/j.cbi.2013.12.017_b0070 article-title: The role of nitric oxide in hypertension and renal disease progression publication-title: Nephrol. Dial. Transplant. doi: 10.1093/ndt/16.suppl_1.60 – volume: 62 start-page: 401 year: 2002 ident: 10.1016/j.cbi.2013.12.017_b0150 article-title: Nitric oxide down-regulates connective tissue growth factor in rat mesangial cells publication-title: Kidney Int. doi: 10.1046/j.1523-1755.2002.00462.x – volume: 223 start-page: 37 year: 2011 ident: 10.1016/j.cbi.2013.12.017_b0115 article-title: Asymmetric dimethylarginine (ADMA) induces chronic kidney disease through a mechanism involving collagen and TGF-beta1 synthesis publication-title: J. Pathol. doi: 10.1002/path.2769 – volume: 6 start-page: 255 year: 2002 ident: 10.1016/j.cbi.2013.12.017_b0180 article-title: Role of Ca(2+)-independent phospholipase A(2) and cyclooxygenase/lipoxygenase pathways in the nitric oxide production by murine macrophages stimulated by lipopolysaccharides publication-title: Nitric oxide doi: 10.1006/niox.2001.0410 – volume: 30 start-page: 396 year: 2011 ident: 10.1016/j.cbi.2013.12.017_b0060 article-title: Interstitial fibrosis is associated with increased COL1A2 transcription in AA-injured renal tubular epithelial cells in vivo publication-title: Matrix Biol. doi: 10.1016/j.matbio.2011.07.004 – volume: 28 start-page: 2253 year: 2007 ident: 10.1016/j.cbi.2013.12.017_b0030 article-title: Aristolochic acid mutagenesis: molecular clues to the aetiology of Balkan endemic nephropathy-associated urothelial cancer publication-title: Carcinogenesis doi: 10.1093/carcin/bgm082 – volume: 294 start-page: F1 year: 2008 ident: 10.1016/j.cbi.2013.12.017_b0065 article-title: Nitric oxide deficiency in chronic kidney disease publication-title: Am. J. Physiol. Renal Physiol. doi: 10.1152/ajprenal.00424.2007 – volume: 31 start-page: 227 year: 2010 ident: 10.1016/j.cbi.2013.12.017_b0170 article-title: Microarray analysis reveals the inhibition of nuclear factor-kappa B signaling by aristolochic acid in normal human kidney (HK-2) cells publication-title: Acta Pharmacol. Sin. doi: 10.1038/aps.2009.197 – volume: 1001 start-page: 1 year: 1989 ident: 10.1016/j.cbi.2013.12.017_b0185 article-title: Effects of aristolochic acid on phospholipase A2 activity and arachidonate metabolism of human neutrophils publication-title: Biochim. Biophys. Acta doi: 10.1016/0005-2760(89)90299-3 – volume: 500 start-page: 255 year: 2004 ident: 10.1016/j.cbi.2013.12.017_b0095 article-title: Regulation of the expression of inducible nitric oxide synthase publication-title: Eur. J. Pharmacol. doi: 10.1016/j.ejphar.2004.07.030 – volume: 192 start-page: 209 year: 2011 ident: 10.1016/j.cbi.2013.12.017_b0175 article-title: Aristolochic acid downregulates monocytic matrix metalloproteinase-9 by inhibiting nuclear factor-kappaB activation publication-title: Chem. Biol. Interact. doi: 10.1016/j.cbi.2011.03.012 – volume: 80 start-page: 1721 year: 2000 ident: 10.1016/j.cbi.2013.12.017_b0135 article-title: Interstitial fibrosis of unilateral ureteral obstruction is exacerbated in kidneys of mice lacking the gene for inducible nitric oxide synthase publication-title: Lab. Invest. doi: 10.1038/labinvest.3780182 – volume: 6 start-page: 283 year: 2002 ident: 10.1016/j.cbi.2013.12.017_b0125 article-title: Antifibrotic role of inducible nitric oxide synthase publication-title: Nitric Oxide doi: 10.1006/niox.2001.0421 – volume: 35 start-page: 200 year: 2009 ident: 10.1016/j.cbi.2013.12.017_b0045 article-title: Connective tissue growth factor: context-dependent functions and mechanisms of regulation publication-title: Biofactors doi: 10.1002/biof.30 – volume: 7 start-page: 2202 year: 1996 ident: 10.1016/j.cbi.2013.12.017_b0130 article-title: Nitric oxide generation ameliorates the tubulointerstitial fibrosis of obstructive nephropathy publication-title: J. Am. Soc. Nephrol. doi: 10.1681/ASN.V7102202 – volume: 261 start-page: 59 year: 2012 ident: 10.1016/j.cbi.2013.12.017_b0200 article-title: Developmental nephrotoxicity of aristolochic acid in a zebrafish model publication-title: Toxicol. Appl. Pharmacol. doi: 10.1016/j.taap.2012.03.011 – volume: 14 start-page: 681 year: 2002 ident: 10.1016/j.cbi.2013.12.017_b0050 article-title: Pathogenesis of fibrosis: role of TGF-beta and CTGF publication-title: Curr. Opin. Rheumatol. doi: 10.1097/00002281-200211000-00009 – volume: 388 start-page: 497 year: 2007 ident: 10.1016/j.cbi.2013.12.017_b0155 article-title: Nitric oxide modulates expression of extracellular matrix genes linked to fibrosis in kidney mesangial cells publication-title: Biol. Chem. doi: 10.1515/BC.2007.056 – volume: 2 start-page: 907 year: 2001 ident: 10.1016/j.cbi.2013.12.017_b0005 article-title: Nitric oxide and the immune response publication-title: Nat. Immunol. doi: 10.1038/ni1001-907 – volume: 30 start-page: 311 year: 1997 ident: 10.1016/j.cbi.2013.12.017_b0020 article-title: Nitric oxide in renal health and disease publication-title: Am. J. Kidney Dis. doi: 10.1016/S0272-6386(97)90275-4 – volume: 27 start-page: 693 year: 2009 ident: 10.1016/j.cbi.2013.12.017_b0165 article-title: Regulation and function of NF-kappaB transcription factors in the immune system publication-title: Annu. Rev. Immunol. doi: 10.1146/annurev.immunol.021908.132641 – volume: 33 issue: 829–837 year: 2012 ident: 10.1016/j.cbi.2013.12.017_b0015 article-title: Nitric oxide synthases: regulation and function publication-title: Eur. Heart J. – volume: 224 start-page: 502 year: 1995 ident: 10.1016/j.cbi.2013.12.017_b0075 article-title: Sample pretreatment with nitrate reductase and glucose-6-phosphate dehydrogenase quantitatively reduces nitrate while avoiding interference by NADP+ when the Griess reaction is used to assay for nitrite publication-title: Anal. Biochem. doi: 10.1006/abio.1995.1079 – volume: 17 start-page: 20 year: 2002 ident: 10.1016/j.cbi.2013.12.017_b0140 article-title: Chronic diabetic nephropathy: role of inducible nitric oxide synthase publication-title: Pediatr. Nephrol. doi: 10.1007/s004670200004 – volume: 20 start-page: 1963 year: 2009 ident: 10.1016/j.cbi.2013.12.017_b0145 article-title: Nitric oxide inhibits glomerular TGF-beta signaling via SMOC-1 publication-title: J. Am. Soc. Nephrol. doi: 10.1681/ASN.2008060653 – volume: 18 start-page: 93 year: 2008 ident: 10.1016/j.cbi.2013.12.017_b0195 article-title: AH23848 accelerates inducible nitric oxide synthase degradation through attenuation of cAMP signaling in glomerular mesangial cells publication-title: Nitric Oxide doi: 10.1016/j.niox.2007.10.005 – volume: 35 start-page: 313 year: 2000 ident: 10.1016/j.cbi.2013.12.017_b0040 article-title: Rapidly progressive fibrosing interstitial nephritis associated with Chinese herbal drugs publication-title: Am. J. Kidney Dis. doi: 10.1016/S0272-6386(00)70343-X |
SSID | ssj0000240 |
Score | 2.134251 |
Snippet | •LPS/IFN-γ-induced NO downregulates CTGF protein expression in MES-13 cells.•AA significantly suppressed LPS/IFN-γ-induced NO production in MES-13 cells.•AA... Aristolochic acid (AA) is a common cause of Chinese herb nephropathy. The mechanisms involved in the pathogenesis of AA nephropathy (AAN) are intricate. One... |
SourceID | proquest pubmed crossref elsevier |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 86 |
SubjectTerms | Aristolochic acid Aristolochic Acids - pharmacology Carcinogens - pharmacology Cell Line Connective tissue growth factor Connective Tissue Growth Factor - genetics Connective Tissue Growth Factor - metabolism Dose-Response Relationship, Drug Down-Regulation - drug effects Glomerular mesangial cells Glomerular Mesangium - cytology Glomerular Mesangium - drug effects Humans Interferon Regulatory Factor-1 - metabolism Interferon-gamma - pharmacology Lipopolysaccharides - pharmacology NF-kappa B - metabolism NF-κB Nitric oxide Nitric Oxide - metabolism Nitric Oxide Synthase Type II - genetics Nitric Oxide Synthase Type II - metabolism Signal Transduction - drug effects STAT-1α STAT1 Transcription Factor - metabolism |
Title | Downregulation of connective tissue growth factor by LPS/IFN-γ-induced nitric oxide is reversed by aristolochic acid treatment in glomerular mesangial cells via STAT-1α and NF-κB signaling |
URI | https://dx.doi.org/10.1016/j.cbi.2013.12.017 https://www.ncbi.nlm.nih.gov/pubmed/24412304 https://www.proquest.com/docview/1499141575 |
Volume | 210 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF61qRBcKmh5pEA1SIgDkonXr7WPaSBKeURITaXerN31OjVqnCp2Eb3wnxA3LvyD_CZm1nYQEvTAzY9debUzntd-M8PYc0ll3aQUDleucAI_0xRo8pwoE64MOXERZSN_mEaT0-DtWXi2xUZdLgzBKlvZ38h0K63bJ4N2NweXRUE5vm7iiYQqzpEmi7fZjofaPu6xneHxu8n0t0D2ArdrqEYTusNNC_PSqiCAl2-DgrZt2V_V07_MT6uGxnfZbms_wrBZ4j22Zco9tj8s0XdeXMMLsIhOGyrfY7eOuqvbo66v2z77-Rod71XTgh6JAsscNKFdrOCD2hIC5uid1-fQdOMBdQ3vP54MjsdTZ_3dQS8e-SEDFAYoRGH5pcgMFBVQMahVhS9wuLQlC1BRnuMIqYsMNoh2KEqYXywXZkUIWFiYSpZz_AuAzhAq-FxIOJkNZw5ffwNZZjAdO-sfR0BAE0m58_fZ6fjNbDRx2jYOjvaiuHaQSXiuckXF3RL0BmOfh3kYSy2UiTwjwyDIeS5cnvlSyjh0tatDk6AwieNcKNd_wHrlsjSPGPhCoUcaeiYROoiQ5lRQL1ZayswYV_M-czvqpbqtcU6tNi7SDsz2KUWCp0TwlHspErzPXm6mXDYFPm4aHHQskf7BpSkqoJumPevYJ0Vi03bK0iyvKnS80D5HG0qEffaw4avNKtDw4hSyP_i_jz5md_AusHi58Anr1asr8xQNqFodsu1XX_lh-5v8AvEgHDc |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELZKESoXBC2U5TlIiAOS2TiJ8zhuF1Zb2K6QupV6ixzH2QZ1k2qzRfTCf0LcuPAP9jcx4ySLkKAHblFsK5FnPA_78zeMvVRE66ZUyEXqhNz3Mk0bTS4PstBRUpAW0W3ko2kwPvHfn8rTLTbs7sIQrLK1_Y1Nt9a6fdNvZ7N_URR0x9eJ3TAmxjnyZNENdtOnMgeo1G--_sZ5EIlXV06NundHmxbkpdOC4F2e3RK0Rcv-6pz-FXxaJzS6y-600SMMmh-8x7ZMucv2BiVmzosreAUWz2k3ynfZrYPuaWfYVXXbYz_fYtq9bArQo0igykET1sWaPVhZMcAcc_PVGTS1eCC9gsnH4_7haMrX3znm8KgNGaApQBMK1ZciM1DUQFRQyxobsLuyhAXoJs-wh9JFBhs8OxQlzM-rhVkS_hUWplblHNcA0AlCDZ8LBcezwYyL9TdQZQbTEV__OACCmSi6OX-fnYzezYZj3hZx4NoNohVHFRF5mqdE7RZjLhh5QuYyUjpMTeAaJX0_F3noiMxTSkXS0Y6WJkZTEkV5mDreA7ZdVqV5yMALU8xHpWviUPsBSpzo9KJUK5UZ42jRY04nvUS3DOdUaOM86aBsnxIUeEICT4SboMB77PVmyEVD73FdZ79TieQPHU3Q_Vw37EWnPgkKm6ZTlaa6rDHtwugcI6hQ9th-o1ebv8CwS9CG_aP_--hztjOeHU2SyeH0w2N2G1t8i5yTT9j2anlpnmIotUqf2aXyC0WWHPk |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Downregulation+of+connective+tissue+growth+factor+by+LPS%2FIFN-%CE%B3-induced+nitric+oxide+is+reversed+by+aristolochic+acid+treatment+in+glomerular+mesangial+cells+via+STAT-1%CE%B1+and+NF-%CE%BAB+signaling&rft.jtitle=Chemico-biological+interactions&rft.au=Tsai%2C+Kuen-Daw&rft.au=Chen%2C+Wei&rft.au=Wang%2C+Sue-Hong&rft.au=Hsiao%2C+Yu-Wei&rft.date=2014-03-05&rft.issn=1872-7786&rft.eissn=1872-7786&rft.volume=210&rft.spage=86&rft_id=info:doi/10.1016%2Fj.cbi.2013.12.017&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0009-2797&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0009-2797&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0009-2797&client=summon |